Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Epidemiological comparison of the first and second waves of the Covid-19 pandemic in Nigeria, February 2020–April 2021

Bibliographic Data

ID21880000
AuthorsOluwatosin Akande (0000-0001-6906-895X, Nigeria Centre for Disease Control, corresponding author), Kelly Elimian (0000-0003-2729-1613, Karolinska Institutet), Ehimario Igumbor (0000-0002-6313-6031, Nigeria Centre for Disease Control), Lauryn Dunkwu (0000-0003-2350-7130, Tony Blair Institute for Global Change, Abuja, Federal Capital Territory, Nigeria), Chijioke Kaduru (0000-0002-6861-9876, Nigeria COVID-19 Research Coalition, Abuja, Federal Capital Territory, Nigeria), Olubunmi Olopha (0000-0002-5950-1868, Nigeria Centre for Disease Control), Olubunmi Omowunmi Olopha (Nigeria Centre for Disease Control), Dabri Olohije Ohanu (Nigeria Centre for Disease Control), Lilian Nwozor (Nigeria Centre for Disease Control), Emmanuel Agogo (0000-0002-3570-3254, Caritas Nigeria), Olusola Aruna (0000-0002-7879-634X, UK Health Security Agency), Muhammad Shakir Balogun (0000-0002-4846-9698, African Field Epidemiology Network), Olaolu Aderinola (0000-0001-6496-6996, Nigeria Centre for Disease Control), Anthony Ahumibe (0000-0002-4651-4424, Nigeria Centre for Disease Control), Chinedu Arinze (0000-0001-7452-1392, Nigeria Centre for Disease Control), Sikiru Badaru (0000-0003-3035-2640, Nigeria Centre for Disease Control), Sikiru Olanrewaju Badaru (Nigeria Centre for Disease Control), William Nwachukwu (0000-0001-7111-1320, Nigeria Centre for Disease Control), Augustine Olajide Dada (0000-0002-1058-3612, African Field Epidemiology Network), Cyril Erameh (0000-0001-7783-2495, Irrua Specialist Teaching Hospital), Khadeejah Liman Hamza (0000-0003-0811-2982, Ahmadu Bello University), Khadeejah Hamza (Ahmadu Bello University), Tarik Benjamin Mohammed (Nigeria Centre for Disease Control), Nnaemeka Ndodo (0000-0003-2792-8311, Nigeria Centre for Disease Control), Celestina Obiekea (0000-0003-2355-5917, Nigeria Centre for Disease Control), Chinenye Ofoegbunam (0000-0002-3330-7178, Nigeria Centre for Disease Control), Oladipo Ogunbode (0000-0001-8337-796X, Nigeria Centre for Disease Control), Cornelius Ohonsi (0000-0002-4727-6835, Nigeria Centre for Disease Control), Ekaete Tobin (0000-0001-5059-807X, Irrua Specialist Teaching Hospital), Rimamdeyati Yashe (Nigeria Centre for Disease Control), Afolabi Adekaiyaoja (Tony Blair Institute for Global Change, Abuja, Federal Capital Territory, Nigeria), Michael C Asuzu (University College Hospital, Ibadan), Rosemary Audu (0000-0002-0330-5219, Nigerian Institute of Medical Research), Rosemary Ajuma Audu (Nigeria COVID-19 Research Coalition, Abuja, Federal Capital Territory, Nigeria), Muhammad Bashir Bello (0000-0001-8986-8188, Usmanu Danfodiyo University), Shaibu Oricha Bello (0000-0001-5380-5759, Usmanu Danfodiyo University), Yusuf Deeni (0000-0002-8529-7469, Development Research and Projects Centre), Yusuf Yahaya Deeni (Nigeria COVID-19 Research Coalition, Abuja, Federal Capital Territory, Nigeria), Yahya Disu (0000-0002-6310-2034, Nigeria Centre for Disease Control), Gbenga Joseph (Nigeria Centre for Disease Control), Chidiebere Ezeokafor (0000-0002-6061-8780, National Agency for the Control of AIDS), Zaiyad Garba Habib (0000-0002-9770-8747, University of Abuja Teaching Hospital), Christian Ibeh (Nigeria COVID-19 Research Coalition, Abuja, Federal Capital Territory, Nigeria), Christian C Ibeh (Nnamdi Azikiwe University Teaching Hospital), Ifeanyi Ike (0000-0002-3030-5433), Ifeanyi Franklin Ike (eHealth Africa, Abuja, Federal Capital Territory, Nigeria), Emem Iwara (0000-0001-8826-1464, Nigeria COVID-19 Research Coalition, Abuja, Federal Capital Territory, Nigeria), Rejoice Kudirat Luka-Lawal (Nigeria Centre for Disease Control), Geoffrey Namara (0009-0005-6209-0413, World Health Organization - Nigeria), Tochi Okwor (0000-0003-2391-7770, Nigeria Centre for Disease Control), Lois Olajide (Nigeria Centre for Disease Control), Oluwafunke Olufemi Ilesanmi (World Health Organization - Nigeria), Solomon Omonigho (University of Benin), Solomon Esharegoma Omonigho (0000-0001-7557-1789, University of Benin), Ferdinand Oyiri (Nigeria Centre for Disease Control), Koubagnine Takpa (Nigeria COVID-19 Research Coalition, Abuja, Federal Capital Territory, Nigeria), Nkem Ugbogulu (Nigeria Centre for Disease Control), Nkem Usha Ugbogulu (Nigeria Centre for Disease Control), Priscilla Ibekwe (Nigeria Centre for Disease Control), John Oladejo (0000-0002-0156-1489, Nigeria Centre for Disease Control), Elsie Ilori (0000-0002-1731-2604, Nigeria Centre for Disease Control), Chinwe Lucia Ochu (0000-0002-0630-7332, Nigeria Centre for Disease Control), Chikwe Ihekweazu (0000-0003-0659-0833, Nigeria Centre for Disease Control)
Year2021
Volume6
Issue11
Pagese007076
Publication date2021-11-01
Peer ReviewedYes
Open AccessYes
TypeARTICLE
VenueBMJ Global Health (JOURNAL)
Journal identifiersISSN: 2059-7908 • E-ISSN: 2059-7908
PublisherBMJ (PUBLISHER • GB)
DOI10.1136/bmjgh-2021-007076
PMID34794956
OpenAlexW3213250881
LanguageEN
Citations received6
References cited22

BACKGROUND: With reports of surges in COVID-19 case numbers across over 50 countries, country-level epidemiological analysis is required to inform context-appropriate response strategies for containment and mitigation of the outbreak. We aimed to compare the epidemiological features of the first and second waves of COVID-19 in Nigeria. METHODS: We conducted a retrospective analysis of the Surveillance Outbreak Response Management and Analysis System data of the first and second epidemiological waves, which were between 27 February and 24 October 2020, and 25 October 2020 to 3 April 2021, respectively. Descriptive statistical measures including frequencies and percentages, test positivity rate (TPR), cumulative incidence (CI) and case fatality rates (CFRs) were compared. A p value of <0.05 was considered statistically significant. All statistical analyses were carried out in STATA V.13. RESULTS: There were 802 143 tests recorded during the study period (362 550 and 439 593 in the first and second waves, respectively). Of these, 66 121 (18.2%) and 91 644 (20.8%) tested positive in the first and second waves, respectively. There was a 21.3% increase in the number of tests conducted in the second wave with TPR increasing by 14.3%. CI during the first and second waves were 30.3/100 000 and 42.0/100 000 respectively. During the second wave, confirmed COVID-19 cases increased among females and people 30 years old or younger and decreased among urban residents and individuals with travel history within 14 days of sample collection (p value <0.001). Most confirmed cases were asymptomatic at diagnosis during both waves: 74.9% in the first wave; 79.7% in the second wave. CFR decreased during the second wave (0.7%) compared with the first wave (1.8%). CONCLUSION: Nigeria experienced a larger but less severe second wave of COVID-19. Continued implementation of public health and social measures is needed to mitigate the resurgence of another wave

Case fatality rate · Disease · Geography · Outbreak · Pandemic · COVID-19 epidemiological studies · Demography · Mathematics · Medicine · SARS-CoV-2 detection and testing · Viral Infections and Outbreaks Research · Epidemiology · Internal Medicine · Virology

  • Evolving trend change during the Covid-19 pandemic

    Open Access•Liping Gao, Canjun Zheng et al.•Frontiers in Public Health•2022

  • Machine learning-driven development of a disease risk score for Covid-19 hospitalization and mortality

    Open Access•Saeed Shakibfar, Jing Zhao et al.•Frontiers in Public Health•2023

  • Epidemiological Trends of Coronavirus Disease 2019 in Sierra Leone From March 2020 to October 2021

    Open Access•Zhiguo Liu, Liping Gao et al.•Frontiers in Public Health•2022

  • Covid19 Sero-epidemiology and vaccine uptake in two Southern Nigerian clinics

    Open Access•Chinedu A Ugwu, Ooreofe Odebode et al.•PLOS Global Public Health•2026

  • Acceptability of Covid-19 self-testing among social and clinical vulnerable populations using a decentralized testing model in Abuja, Nigeria; A mixed methods analysis of an implementation study

    Open Access•Elvis Isere, John Bimba et al.•PLOS Global Public Health•2026

  • A comparative analysis of experienced uncertainties in relation to risk communication during Covid19

    Open Access•Florin Cristea, Heide Weishaar et al.•Globalization and Health•2022

  • Gender differences in Covid-19 attitudes and behavior

    Open Access•Vincenzo Galasso, Vincent Pons et al.•Proceedings of the National…•2020

  • The first and second waves of the Covid-19 pandemic in Africa

    Open Access•Stephanie J Salyer, Justin Maeda et al.•The Lancet•2021

  • Lessons from co-production of evidence and policy in Nigeria’s Covid-19 response

    Open Access•Ibrahim Abubakar, Sarah L Dalglish et al.•BMJ Global Health•2021

  • Nigeria’s public health response to the Covid-19 pandemic

    Open Access•Chioma Dan-Nwafor, Chinwe Lucia Ochu et al.•Journal of Global Health•2020

  • Covid-19 mortality risk for older men and women

    Open Access•N David Yanez, Noel S Weiss et al.•BMC Public Health•2020

Unique citing works6
Citations per year1,5
Citation span2022 - 2026 (5)
Citation velocitycurrent
Highly citedNo
Citation typesNeutral: 6
Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae